Kasisto Appoints Don Layden as Executive Chairman of the Board of Directors and Closes Series D Funding Round
| |

Kasisto Appoints Don Layden as Executive Chairman of the Board of Directors and Closes Series D Funding Round

Kasisto, the creators of the KAI conversational AI platform for financial services, have appointed Don Layden as Executive Chairman of the Board of Directors. This announcement coincides with the successful closing of Kasistos Series D funding round, totaling $90 million. The funding will further solidify Kasistos position in providing conversational and generative AI solutions to…

CSA Medical Inc. Completes $53 Million Series D Funding Round
| |

CSA Medical Inc. Completes $53 Million Series D Funding Round

CSA Medical Inc., developer of The RejuvenAir® System, a Breakthrough Medical Device advancing the power of liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis, has announced the completion of an oversubscribed $53 million Series D preferred stock equity financing. The funding round will support the company through expected U.S. Food and Drug Administration…

Oyster Raises $59M in Series D Funding to Accelerate Global Employment Solution
| | |

Oyster Raises $59M in Series D Funding to Accelerate Global Employment Solution

Oyster®, a global employment platform, recently secured $59M in Series D funding led by Silver Lake Waterman. The funding round also saw continued support from existing investors including Emergence Capital, Stripes, Georgian, G2 Venture Partners, and Endeavor Catalyst. With this latest investment, Oyster aims to expedite its platform roadmap, scale its impact, enhance its customers…

Circle Pharma Secures $90 Million Series D Funding Round
| | | | |

Circle Pharma Secures $90 Million Series D Funding Round

South San Franciscobased Circle Pharma, a clinicalstage biopharmaceutical company focused on developing cellpermeable macrocycles as novel therapies, recently closed a successful $90 million Series D financing round, including a convertible note conversion. The funding will primarily support the clinical development of CID078, their cyclin A/B RxL inhibitor, and further advance their portfolio of discovery programs…

HomeLight Secures $20 Million Funding to Expand Buy Before You Sell Program
| |

HomeLight Secures $20 Million Funding to Expand Buy Before You Sell Program

HomeLight, a real estate technology platform, has announced a $20 million funding round to support the expansion of its Buy Before You Sell program. The program addresses the common issue faced by homebuyers who need to sell their existing home before purchasing a new one. With the use of AI technology, HomeLights Buy Before You…

Neptune Medical Spins Out Jupiter Endovascular Following $97 Million Series D Financing
| | |

Neptune Medical Spins Out Jupiter Endovascular Following $97 Million Series D Financing

Neptune Medical, a leader in medical device innovation, successfully spun out its subsidiary, Jupiter Endovascular, after closing a $97 million Series D financing round. The funding will strengthen Neptune Medicals focus on gastrointestinal robotics, with Dr. Fred Moll appointed as Chairman of the Board. Meanwhile, Jupiter Endovascular will leverage the funding to advance its novel…

HistoSonics Secures $102 Million in Series D Funding
| | |

HistoSonics Secures $102 Million in Series D Funding

HistoSonics, a medical device company specializing in noninvasive platforms and sonic beam therapy utilizing histotripsy, has successfully completed an oversubscribed $102 million Series D financing round. The funding will be used to advance their noninvasive histotripsy platforms, support commercial growth in the US and global markets, and launch the innovative BOOMBOX Master Study to evaluate…

EliseAI Raises $75 Million in Series D Funding
| | | |

EliseAI Raises $75 Million in Series D Funding

EliseAI, a leading conversational AI platform for the housing industry, has secured $75 million in its Series D funding round led by Sapphire Ventures. Existing investors Navitas Capital, Point72 Private Investments, DivcoWest Ventures, and Koch Real Estate Investments also participated in the round. The funding will be utilized by EliseAI to further enhance its AIdriven…

Global Alternative Investment Management LLC Closes Fund for Strategic Investment in AI Technology Company Groq
| | | | |

Global Alternative Investment Management LLC Closes Fund for Strategic Investment in AI Technology Company Groq

Global Alternative Investment Management LLC (Global Alts) has successfully closed its latest venture capital fund, Global Alts SPV LLCGroq AI, aimed at a strategic investment in Groq, a cuttingedge AI technology firm focused on developing chips for faster generative AI model processing. The Funds investment in Groq was carried out through a private investment vehicle…

TMRW Life Sciences Raises $28 Million Series D Funding to Meet Growing Demand for Fertility Clinic Cryostorage Solutions
| |

TMRW Life Sciences Raises $28 Million Series D Funding to Meet Growing Demand for Fertility Clinic Cryostorage Solutions

TMRW Life Sciences, the creator of an FDAcleared automated specimen management and storage platform for frozen human sperm, eggs, and embryos, has secured a $28 million Series D equity financing round. The funding will be used to address the increasing demand from fertility clinics for safer and more accurate cryostorage solutions. The funding round was…